A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patientsPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92013-01-0116PREAI
Comparison of perospirone and aripiprazole: a 12 weeks, randomised, open-label study in Japanese schizophrenia patientsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72011-09-010PREAI
Differences in quantitative EEG between frontotemporal dementia and Alzheimer's disease as revealed by LORETACLINICAL NEUROPHYSIOLOGYIF3.62011-09-0164PREAI
Olfactory reference syndrome treated by blonanserin augmentationPSYCHIATRY AND CLINICAL NEUROSCIENCESIF6.22011-03-173OAAI
Effect of the DRD2 Taq 1A polymorphism on perospirone and aripiprazole efficacy for Japanese schizophrenia patientsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Syndrome of inappropriate secretion of anti-diuretic hormone in an elderly depressive patient receiving paroxetine: a case reportINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82010-03-107PREAI